Institution
ICM Partners
About: ICM Partners is a based out in . It is known for research contribution in the topics: Population & Breast cancer. The organization has 1311 authors who have published 1521 publications receiving 33745 citations. The organization is also known as: International Creative Management Partners.
Topics: Population, Breast cancer, Cancer, Cognition, Radiation therapy
Papers published on a yearly basis
Papers
More filters
••
TL;DR: These findings provided evidence of frequent (37%) loss-of-function mutations in DEPDC5 associated with a broad spectrum of focal epilepsies and the implication of a DEP domain–containing protein that may be involved in membrane trafficking and/or G protein signaling opens new avenues for research.
Abstract: The main familial focal epilepsies are autosomal dominant nocturnal frontal lobe epilepsy, familial temporal lobe epilepsy and familial focal epilepsy with variable foci. A frameshift mutation in the DEPDC5 gene (encoding DEP domain-containing protein 5) was identified in a family with focal epilepsy with variable foci by linkage analysis and exome sequencing. Subsequent pyrosequencing of DEPDC5 in a cohort of 15 additional families with focal epilepsies identified 4 nonsense mutations and 1 missense mutation. Our findings provided evidence of frequent (37%) loss-of-function mutations in DEPDC5 associated with a broad spectrum of focal epilepsies. The implication of a DEP (Dishevelled, Egl-10 and Pleckstrin) domain-containing protein that may be involved in membrane trafficking and/or G protein signaling opens new avenues for research.
208 citations
••
TL;DR: To elucidate the causal implication of brain regions that were related to punishment learning in a previous functional neuroimaging study, the effects of brain damage on behavioral performance were tested, using the same task contrasting monetary gains and losses.
208 citations
••
University of North Texas Health Science Center1, Edith Cowan University2, University of North Texas3, AXA4, King's College London5, Bristol-Myers Squibb6, ICM Partners7, Pierre-and-Marie-Curie University8, University of Washington9, Sahlgrenska University Hospital10, Indiana University11, Alzheimer's Association12, Mayo Clinic13, University of Tübingen14, German Center for Neurodegenerative Diseases15, University of Pennsylvania16, Columbia University17, University of California, San Diego18, Washington University in St. Louis19, University of California, San Francisco20, Texas Tech University Health Sciences Center21, Pfizer22
TL;DR: The lack of readily available biomarkers is a significant hindrance toward progress to effective therapeutic and preventative strategies for Alzheimer's disease (AD) as discussed by the authors, and the current international working group provides the initial starting point for such guidelines for standardized operating procedures.
Abstract: The lack of readily available biomarkers is a significant hindrance toward progressing to effective therapeutic and preventative strategies for Alzheimer's disease (AD). Blood-based biomarkers have potential to overcome access and cost barriers and greatly facilitate advanced neuroimaging and cerebrospinal fluid biomarker approaches. Despite the fact that preanalytical processing is the largest source of variability in laboratory testing, there are no currently available standardized preanalytical guidelines. The current international working group provides the initial starting point for such guidelines for standardized operating procedures (SOPs). It is anticipated that these guidelines will be updated as additional research findings become available. The statement provides (1) a synopsis of selected preanalytical methods utilized in many international AD cohort studies, (2) initial draft guidelines/SOPs for preanalytical methods, and (3) a list of required methodological information and protocols to be made available for publications in the field to foster cross-validation across cohorts and laboratories.
204 citations
••
TL;DR: It is shown that low-dose interleukin-2 (ld-IL-2) safely expands/activates Tregs in patients with AID, such HCV-induced vasculitis and Type 1 Diabetes (T1D), and relevant for further development of ld- IL-2 for therapy and prevention of T1D, and other autoimmune and inflammatory diseases.
195 citations
•
23 Aug 2006TL;DR: In this article, a process arrangement for distilling fuel grade ethanol include a distillation portion which distills beer to produce thin stillage and hot ethanol vapor in an evaporation portion, a set of first effect evaporators which are heated either by plant steam or hot ethanol vapour while producing first effect steam.
Abstract: A process arrangement for distilling fuel grade ethanol include a distillation portion which distills beer to produce thin stillage and hot ethanol vapor In an evaporation portion, a set of first effect evaporators which are heated either by plant steam or hot ethanol vapor, concentrate thin stillage into mid stillage while producing first effect steam The first effect steam from the first effect evaporators provides heat to a set of second effect evaporators which concentrate the mid stillage into a syrup for further drying The second effect evaporators produce second effect steam which is used to heat the distillation portion of the process arrangement The multiple evaporators of the first and second effects of the evaporation portion can be selectively taken off-line for maintenance while the evaporation portion and the remainder of the process arrangement continue to operate at full capacity
195 citations
Authors
Showing all 1311 results
Name | H-index | Papers | Citations |
---|---|---|---|
Alexis Brice | 135 | 870 | 83466 |
Bruno Dubois | 124 | 646 | 78784 |
Harald Hampel | 109 | 601 | 65160 |
Alexandra Durr | 104 | 594 | 47018 |
Laurent D. Cohen | 94 | 417 | 42709 |
Jürgen Eckert | 92 | 1368 | 42119 |
Stéphane Lehéricy | 89 | 332 | 27214 |
Antoine Danchin | 80 | 483 | 30219 |
Marie Vidailhet | 79 | 391 | 21836 |
Josep M. Gasol | 77 | 313 | 22638 |
Mélanie Boly | 76 | 232 | 21552 |
Etienne C. Hirsch | 75 | 218 | 22591 |
Måns Ehrenberg | 74 | 234 | 17637 |
Elizabeth M. C. Fisher | 74 | 298 | 21150 |
Isabelle Arnulf | 73 | 331 | 18456 |